Company / Shares Outstanding
Tempest Therapeutics, Inc. Shares Outstanding History
FY2015-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
35.6M
FY2017
5-year range
24.1M / 35.6M
FY2015-FY2017
Trend
+30.6%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from 24084637.00 to 35641505.00 over the past 2 years.
Based on SEC 10-K filings.
35641505.00 in FY2017.
Increased from 24084637.00 to 35641505.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, shares outstanding increased 30.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | 35.6M | +30.6% |
| FY2016 | 27.3M | +13.3% |
| FY2015 | 24.1M | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026